Abstract: A method of treating and/or preventing infectious disease in mammals, such as canines, includes administering an effective amount of a colostral composition to a mammal which has been produced by a donor mammal and includes at least one type of antibody having a binding specificity for at least one pathogen. The at least one type of antibody is generated by the donor mammal in response to being challenged with at least one challenge material.

Abstract: Hyaluronic acid nutritional supplements and methods of using the same. In at least one embodiment of a nutritional supplement of the present disclosure, the nutritional supplement comprises a quantity of a hyaluronic acid, or a salt or digest thereof, and a food acceptable carrier.

Abstract: The present disclosure includes disclosure of various embodiments of composition comprising a therapeutically-effective amount of a hyaluronate and a therapeutically-effective amount of colostrum. In at least one embodiment, the hyaluronate comprises sodium hyaluronate, and the colostrum comprises bovine colostrum. In an exemplary method of reducing osteoblastic activity within a warm-blooded vertebrate, the method comprises the step of administering a composition comprising a therapeutically-effective amount of a hyaluronate and a therapeutically-effective amount of colostrum to the warm-blooded vertebrate.

Abstract: Hyaluronic acid nutritional supplements and methods of using the same. In at least one embodiment of a nutritional supplement of the present disclosure, the nutritional supplement comprises a quantity of a hyaluronic acid, or a salt or digest thereof, and a food acceptable carrier.

Abstract: Methods and compositions are described for relieving joint pain and discomfort in a warm-blooded vertebrate by delivering via oral ingestion a nutritional supplement comprising an effective amount of hyaluronic acid, or a salt or digest thereof, and a nutritionally acceptable carrier.

Abstract: Colostrum products and a methods of using the colostrum products are provided. Methods are provided for preparing the colostrum products, which may be filtered and sterilized. The colostrum products may be injected, illustratively subcutaneously and intravenously, to provide an animal protection from disease.

Abstract: Methods and compositions are described for relieving joint pain and discomfort in a warm-blooded vertebrate by delivering via oral ingestion a nutritional supplement comprising an effective amount of hyaluronic acid, or a salt or digest thereof, and a nutritionally acceptable carrier.

Abstract: Methods are described for relieving discomforts associated with osteoarthritis or fibromyalgia. The methods comprise the step of delivering by oral ingestion a nutritional supplement consisting essentially of an effective amount of hyaluronic acid, or a salt or digest thereof, and a food acceptable carrier, wherein the effective amount of hyaluronic acid, or a salt or digest thereof, is from about 0.1 &mgr;g to about 400 &mgr;g/kg of body weight.

Abstract: A method is described for relieving joint pain and discomfort in a warm-blooded vertebrate by delivering via oral ingestion a nutritional supplement comprising an effective amount of hyaluronic acid, or a salt or digest thereof, and a nutritionally acceptable carrier. In another embodiment of the present invention, a method is provided for reducing the discomfort of fibromyalgia in a person afflicted with fibromyalgia by delivering via oral ingestion a nutritional supplement comprising an effective amount of hyaluronic acid, or a salt or digest thereof, and a nutritionally acceptable carrier.

Abstract: An immunological serum and method of making same. The serum essentially consists of purified and concentrated materials, sometimes known as transfer factor, and immunoglobulins, expressed from the clotted blood of a donor group having known immunity. To produce the serum, a group of donors is chosen which includes known immunity, preferably to a wide variety of ailments. Blood is drawn from the donor group and allowed to clot. Thereafter, the blood is filtered to remove all cellular material, producing raw serum. This raw serum is then concentrated by removal of water. The concentrated serum is then sterilized, but not denatured, by freezing and gamma irradiation.